1/63
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Dr. Joseph J.
Instructor for the NEUR 2000 course.
Mental Illness
Difficult to classify due to behavior variability.
DSM-V
Diagnostic tool for mental disorders, 5th edition.
Prevalence of Mental Illness
20% of U.S. population affected.
Sexually Dimorphic Disorders
Disorders differing in prevalence by sex.
Schizophrenia
Chronic disorder affecting 1-2% of U.S. population.
Depression
Most prevalent mood disorder in the U.S.
Symptoms of Depression
Unhappy mood, low energy, hopelessness, agitation.
Suicide Risk
80% of suicides linked to depression.
Heritability of Depression
20% concordance in dizygotic twins, 60% in monozygotic.
SSRIs
Selective serotonin reuptake inhibitors for treating depression.
Antidepressants
Drugs increasing monoamine neurotransmitter levels.
Cognitive Behavioral Therapy
Talk therapy altering behavior through thought changes.
Transcranial Magnetic Stimulation
Magnetic field applied to brain for depression treatment.
Electroconvulsive Therapy
Induces seizures to treat severe depression.
Chlorpromazine
First drug treating psychotic symptoms of schizophrenia.
Antipsychotics
Drugs treating schizophrenia and other psychotic disorders.
Neurodegenerative Diseases
Cause neuronal and glial cell loss.
Paralytic Dementia
Historical psychiatric illness linked to syphilis.
5HT2A Receptor Variant
Common in suicide victims, linked to depression.
Functional Imaging
Reveals decreased frontal cortex activity in schizophrenia.
Enlarged Cerebral Ventricles
Structural change in some schizophrenic brains.
Dysbindin
Gene implicated in synaptic plasticity related to schizophrenia.
Neurregulin 1
Regulates neurotransmitter receptors, linked to schizophrenia.
Catechol-O-methyltransferase (COMT)
Gene involved in dopamine metabolism.
G72 Gene
Contributes to glutamate activity in schizophrenia.
Disrupted in Schizophrenia 1 (DISC1)
Gene mutation linked to high schizophrenia rates.
Treatment-Resistant Depression
Depression not responding to standard treatments.
Side Effects of SSRIs
Commonly include sexual dysfunction and nausea.
Cognitive Behavioral Therapy Effectiveness
Comparable to drug therapies for treating depression.
Amyotrophic lateral sclerosis
Progressive neurodegenerative disease affecting motor neurons.
Huntington's Disease
Genetic disorder causing progressive brain degeneration.
Parkinson's Disease
Movement disorder due to dopamine-producing neuron loss.
Alzheimer's Disease
Common late-life neurodegenerative disease affecting memory.
AD prevalence
6% of adults aged 65+ have Alzheimer's.
AD symptom progression
Symptoms worsen from mild to severe over years.
Initial AD symptoms
Short-term memory issues and attention problems.
Later AD symptoms
Long-term memory loss and cognitive impairment.
Emotional impact of AD
High emotional cost for families of patients.
AD brain changes
Loss of cerebral cortex and hippocampus observed.
Beta-amyloid accumulation
Protein buildup outside neurons in Alzheimer's patients.
Neural signaling disruption
Potential impairment in communication between neurons.
Acetylcholine
Neurotransmitter crucial for learning and memory.
Alzheimer's Disease (AD)
Progressive neurodegenerative disorder affecting memory.
Beta-amyloid protein
Protein linked to Alzheimer's disease pathology.
Early onset AD
Subtype of AD affecting individuals in their 40s.
Amyloid precursor protein
Gene mutations associated with early onset AD.
Acetylcholinesterase inhibitors
Medications like Aricept to increase acetylcholine.
Excitotoxicity
Neuronal death due to excessive glutamate stimulation.
Stroke
Cell death from disrupted blood flow to brain.
Ischemic stroke
Blocked blood vessel prevents blood flow to brain.
Hemorrhagic stroke
Broken blood vessel leaks blood, reducing brain flow.
Middle cerebral artery
Common blockage site causing motor function loss.
Broca's aphasia
Language impairment due to left hemisphere damage.
Traumatic brain injury (TBI)
Brain injury from external physical force.
Cerebrospinal fluid
Fluid that cushions the brain and spinal cord.
Neuroprotective drugs
Experimental treatments aimed at protecting brain cells.
Physical therapy
Rehabilitation to restore movement post-injury.
Cognitive therapy
Restoration of cognitive functions after brain injury.
Psychotherapy
Mental health support for coping with TBI.
Inflammatory responses
Body's reaction that can worsen brain injury effects.
Daily low dose aspirin
Preventative treatment to reduce blood clotting.
Plasticity of the brain
Brain's ability to reorganize and adapt after injury.
High cholesterol
Risk factor for stroke and cardiovascular diseases.